Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response

被引:53
作者
Mittal, SK
Aggarwal, N
Sailaja, G
van Olphen, A
HogenEsch, H
North, A
Hays, J
Moffatt, S
机构
[1] Purdue Univ, Sch Vet Med, Dept Vet Pathobiol, W Lafayette, IN 47907 USA
[2] Purdue Univ, Lab Anim Program, W Lafayette, IN 47907 USA
关键词
biodegradable microsphere; adenovirus; mucosal immune response; systemic immune response; gene delivery vehicle; DNA immunization;
D O I
10.1016/S0264-410X(00)00170-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the potential for biodegradable alginate microspheres to be used as a delivery vehicle for DNA based vaccines, we constructed a plasmid, pMNe-gal-SV40, containing the bacterial P-galactosidase (LacZ) gene under the control of the murine cytomegalovirus (MCMV) immediate-early promoter and the simian virus 40 (SV40) polyadenylation signal. The effect of the route of administration and co-administration of adenovirus on systemic and mucosal immune responses were investigated. Mice were inoculated orally, intranasally (i.n.), intramuscularly (i.m,), subcutaneously (s.c.) or intraperitoneally (i.p.) on days 0, 14 and 28 with microspheres containing plasmid DNA, bovine adenovirus type 3 (BAd3) or plasmid DNA + BAd3. Systemic routes of immunization (i.m., s.c, and i.p.) resulted in higher LacZ- or BAd3-specific IgG ELISA titers compared to those obtained by mucosal routes of inoculation (oral and i.n.). Mucosal immunization led to slightly higher titers of LacZ- or BAd3-specific IgA at mucosal sites compared to those obtained by the various systemic routes. All the routes of immunization induced LacZ-specific lymphoproliferation. Co-administration of BAd3 enhanced the LacZ-specific IgG response irrespective of the route of administration. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 49 条
[1]   Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors [J].
Addison, CL ;
Hitt, M ;
Kunsken, D ;
Graham, FL .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1653-1661
[2]  
Aggarwal N, 1999, CAN J VET RES, V63, P148
[3]   GENE-TRANSFER OPTIMIZATION WITH LIPOSPERMINE-COATED DNA [J].
BARTHEL, F ;
REMY, JS ;
LOEFFLER, JP ;
BEHR, JP .
DNA AND CELL BIOLOGY, 1993, 12 (06) :553-560
[4]   Oral vaccination with alginate microsphere systems [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Porter, RE ;
Jackson, R ;
Park, H ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :209-220
[5]   Oral vaccination of animals with antigens encapsulated in alginate microspheres [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Guimond, P ;
Martin, S ;
Borie, D ;
Torregrosa, S ;
Park, H ;
Park, K .
VACCINE, 1999, 17 (13-14) :1804-1811
[6]  
Bowersock TL, 1997, CONTROLLED DRUG DELI, P269
[7]   Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope [J].
Casares, S ;
Inaba, K ;
Brumeanu, TD ;
Steinman, RM ;
Bona, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1481-1486
[8]   A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation [J].
Caver, TE ;
Lockey, TD ;
Srinivas, RV ;
Webster, RG ;
Hurwitz, JL .
VACCINE, 1999, 17 (11-12) :1567-1572
[9]   Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles [J].
Chen, SC ;
Jones, DH ;
Fynan, EF ;
Farrar, GH ;
Clegg, JCS ;
Greenberg, HB ;
Herrmann, JE .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5757-5761
[10]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128